Frank Mottola - Feb 22, 2024 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
SVP, Quality, GMP, Ops, IT
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Stock symbol
SUPN
Transactions as of
Feb 22, 2024
Transactions value $
-$9,360
Form type
4
Date filed
2/26/2024, 05:00 PM
Previous filing
Nov 16, 2023
Next filing
Feb 27, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SUPN Common Stock Award $0 +750 +12.72% $0.00 6.65K Feb 22, 2024 Direct F1
transaction SUPN Common Stock Tax liability -$9.36K -335 -5.04% $27.94 6.31K Feb 22, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Restricted Stock Unit Disposed to Issuer $0 -750 -33.33% $0.00 1.5K Feb 22, 2024 Common Stock 750 Direct F3, F4
transaction SUPN Restricted Stock Unit Award $0 +5K $0.00 5K Feb 22, 2024 Common Stock 5K Direct F3, F5
transaction SUPN Employee Stock Option (Right to Buy) Award $0 +25K $0.00 25K Feb 22, 2024 Common Stock 25K $27.94 Direct F6
transaction SUPN Performance Share Unit Award $0 +990 $0.00 990 Feb 22, 2024 Common Stock 990 $0.00 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes an aggregate of 215 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
F2 Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting.
F3 Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
F4 These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023.
F5 These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025.
F6 The option vests in four equal annual installments beginning on February 22, 2025.
F7 On February 22, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2022.